Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease
The course and complications of coronary artery disease (CAD) are associated with atherosclerosis progression and a high probability of atherothrombosis. Antithrombotic therapy is the most effective strategy for preventing cardiovascular events in atherosclerotic diseases. In accordance with current...
Saved in:
Main Authors: | N. V. Lomakin, I. Yu. Tkach, E. A. Shirokov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2025-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/6286 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE
by: V. N. Khirmanov
Published: (2018-04-01) -
APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01) -
NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01) -
Scrotal variceal bleeding during rivaroxaban therapy as alarming sign in senescent patients: A clinical case
by: S. A. Chepurnenko, et al.
Published: (2022-06-01) -
Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation
by: S. G. Kanorskii
Published: (2016-09-01)